Short Interest in XOMA Co. (NASDAQ:XOMAP) Expands By 58.5%

XOMA Co. (NASDAQ:XOMAP) was the target of a significant growth in short interest during the month of February. As of February 15th, there was short interest totalling 6,500 shares, a growth of 58.5% from the January 31st total of 4,100 shares. Based on an average trading volume of 1,100 shares, the short-interest ratio is currently 5.9 days.

XOMA Stock Down 0.2 %

XOMAP stock opened at $25.78 on Tuesday. The company has a 50-day simple moving average of $25.68 and a 200 day simple moving average of $25.76. XOMA has a fifty-two week low of $24.61 and a fifty-two week high of $26.51.

About XOMA

XOMA Royalty Corporation operates as a biotech royalty aggregator in the United States and the Asia Pacific. It has a portfolio of economic rights to future potential milestone and royalty payments associated with partnered commercial and pre-commercial therapeutic candidates. The company also focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to partners; and acquires milestone and royalty revenue streams on late-stage clinical or commercial assets.